Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02854046

Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesions with ulceration mostly located on the trunk or thigh. Current knowledge about physiopathology, diagnostic practice and therapeutic is very limited. Actually there is no European study about calciphylaxis and risk factors, diagnostic practice and outcome factors.

Official title: Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome : a Multicentric, Retrospective Cohort

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2016-07-01

Completion Date

2016-10-31

Last Updated

2026-06-24

Healthy Volunteers

No

Conditions

Interventions

OTHER

Calcific Uremic Arteriolopathy

Locations (1)

CHU de Nantes

Nantes, France